Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • RESEARCH HIGHLIGHT

Combination therapy alleviates AD-related pathologies

By
  1. Sarah Crunkhorn
Access through your institution
Buy or subscribe

Current therapeutic options for Alzheimer disease (AD) are largely limited to symptom-managing treatments. Given the unmet need for disease-modifying therapies and limited success of single-target approaches, strategies addressing the multifactorial and heterogeneous nature of AD are needed.

Access options

Access through your institution

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Learn more

Prices may be subject to local taxes which are calculated during checkout

Nature Reviews Drug Discovery 24, 742 (2025)

doi: https://doi.org/10.1038/d41573-025-00146-3

References

  1. Li, Y. et al. Cell-type-directed network-correcting combination therapy for Alzheimer’s disease. Cell https://doi.org/10.1016/j.cell.2025.06.035 (2025)

Download references

Nature Careers

Jobs

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing

Search

Advanced search

Quick links